In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
How RBM Is Changing The Role Of Monitors
Clara Heering is mentioned in this article to do with howrisk based monitoringis changing the role of monitors.
-
Challenges in Manufacturing and Distribution of CAR-T Therapies
ICON experts contribute to this Pharmafocus article on the challenges in the manufacturing and distribution ofCAR-T therapies for patients.
-
Innovative CROs Support a More Integrated R&D Model
For the past decade, the pharma industry has been working to overcome what many called a “crisis” in R&D productivity.
-
-
Challenges Faced in Patient Recruitment and Retention
Mary Pan contributes to this thought leadership article on the challenges faced inpatient recruitment and retention in clinical trials inPharma Focus Asia.
-
ELITE 2018 Transformational Leader
An article on Lee Termini's recognition as a ‘transformational leader’ and how he has brought value to market access and reimbursement.
-
Holistic Approach
A thought leadership article on the 'Improving Pharma R&D Efficiency - Transforming Trials' white paper; an industry survey conducted by ICON in collaboration with ISR Research and Informa's Pharma Intelligence to examine the challenges facing pharma and find solutions, including a holistic approach to transforming the clinical trial process.
-
ICON and DuPage Medical forge clinical research partnership
Review commentary from EB McLindon on the ICON and DuPage partnership in this article.
-
Big Data Drives Drug Development Efforts
An article featuring commentary from Nuala Murphy on the rise of precision therapies, and big data are the driving forces impacting Contract Research Organisations (CROs), and how CROs need to provide solutions that are both innovative and efficient and technology is playing a vital role in efforts to streamline clinical operations.
-
Constant Vigilance
Tony Clarke outlines how safe design and proactive risk management throughout product lifecycles can mitigatemedicaland financial risks in this article, taken frompages 84-87 of European Biopharmaceutical Review - Winter 2018 (January) - Samedan Ltd.
